Innovation Pharmaceuticals Inc (IPIX)

[To infinity and beyond!]

Caution required on Kevetrin certainly. At this point just searching for correct dosing,with hope to go on, some science, but mostly hopes. It is still so early.

Let's take the last published report about the vanishing spleen lesion. Lower in the article it says the patient's CA125(tumor marker) continued to rise, suggesting that change in ascites and spleen lesion was telling only part of the story.

Many here are gambling that there will be a payoff, and the stock has risen for quite a while.It is surely a gamble though.

Take away Kevetrin and how much will B and Prurisol be worth? Hard to be sure.